Medacta Drives Robust Growth Across Segments and Regions

Medacta reported 2H23 orthopedic sales of EUR 255.6 million ($276 million USD), +13.2% compared to the second half of 2022. The company generated EUR 510.8 million ($551.6 million USD) in 2023, growing 16.9% compared to the prior year.

The company's joint replacement growth is well above market average, which is especially impressive...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us